271 Consistent high-quality dendritic cell vaccines produced post-chemotherapy in patients with acute myeloid leukemia for use in a Phase I/II trial

• Gunnar Kvalheim,
• Frauke Schnorfeil,
• Christiane Geiger,
• Iris Bigalke,
• Dolores Schendel,
• Dag Josefsen,
• Yngvar Floisand,
• Anna Tafuri,
• Kai Pinkernell

Affiliations

Gunnar Kvalheim

2Oslo University Hospital, Oslo, Norway

Frauke Schnorfeil

1Medigene Immunotherapies GmbH, Martinsried, Germany

Christiane Geiger

1Medigene Immunotherapies GmbH, Martinsried, Germany

Iris Bigalke

2Oslo University Hospital, Oslo, Norway

Dolores Schendel

3Medigene AG, Planegg-Martinsried, Germany

Dag Josefsen

2Oslo University Hospital, Oslo, Norway

Yngvar Floisand

2Oslo University Hospital, Oslo, Norway

Anna Tafuri

1Medigene Immunotherapies GmbH, Martinsried, Germany

Kai Pinkernell

3Medigene AG, Planegg-Martinsried, Germany